Active	Status	Sponsor type	Region	Phase	Filter
1 Active 10 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Xegafri (rociletinib) / Clovis
NCT02547675: Rociletinib (CO-1686) USA Expanded Access Program	No Longer Available	N/A		US	Rociletinib, CO-1686	Clovis Oncology, Inc.	Non-small Cell Lung Cancer